Table 1.
Clinical characteristics of study subjects
| N | 585 |
|---|---|
| Women/Men | 422/163 |
| Age (yr) | 42 (31-52) |
| Body Mass Index (Kg/m2)a | 41 (36.5-47.5) |
| SBP (mm/Hg) | 130 (120-140) |
| DBP (mm/Hg) | 80 (80-90) |
| Triglycerides (mg/dL) | 113 (81-157.2) |
| Total Cholesterol (mg/dL) | 200 (178-227.1) |
| HDL Cholesterol (mg/dL) | Male: 43 (38.1-49.1) Female: 50 (44-58.5) |
| LDL Cholesterol (mg/dL) | 122 (103.5-146.2) |
| ALT (U/L) | 28 (20.5-43) |
| AST (U/L) | 20 (16-26) |
| Fasting blood glucose (mg/dL) | 90 (82-99) |
| Fasting blood insulin (μU/mL) | 24 (16.3-35) |
| HOMA-IR (U) | 5.1 (3.4-8.4) |
| ISI (U) | 2.1 (1.4-3.4) |
| Type 2 diabetes n (%) | 40 (6.8) |
a BMI was calculated as body weight (kg)/height (m2). Values are medians and interquartile ranges. Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL, high density lipoprotein; LDL, low density lipoprotein; ALT, alanine transaminase; AST, aspartate transaminase; HOMA-IR, homeostatic model assessment of insulin resistance; ISI, insulin sensitivity index.